Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
LabCorp
Podcast
'The Top Line': The TIGIT aftermath, Q1 revenue growth and more
This week on "The Top Line," we discuss what's left in the wake of Roche’s failed TIGIT drug and which companies had the biggest Q1 revenue growth.
Teresa Carey
May 20, 2022 9:00am
Blueprint's Ayvakit launch ramps up as Rossi takes COO role
Jan 7, 2022 5:24am
COVID-19 tracker: New variant, J&J, boosters and more
Nov 29, 2021 10:00am
COVID-19 tracker: Pfizer, Moderna and more
Apr 28, 2021 8:57am
COVID-19 tracker: Regeneron, Novo, CDC, Scripps, AZ and more
Oct 30, 2020 3:30pm
COVID-19 tracker: Sinovac, Daewoong, SII, AstraZeneca and more
Aug 11, 2020 9:30am